Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 study

por Joseph F Merola, Frank Behrens, Marina Magrey, Liang Chen, Derek Haaland, Koji Kato, Mitsumasa Kishimoto, Patrick Zueger, Aileen L Pangan, Cesar Pacheco-Tena, John Liu, Yuanyuan Duan, Ralph Lippe
Publicado 2021